Accuitis Inc. — Form D/A
Accuitis Inc. of ALPHARETTA, GA, a company, filed a Form D amendment with the SEC on 2016-07-01. The offering totals $1.5M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-07-01
- Form: D/A
- Accession: 0001634848-16-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.0M
- Remaining: $500K
- Minimum investment: $10K
- Investors: 15
- Date of first sale: 2015-01-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-236349
Issuer
- Name: Accuitis Inc.
- CIK: 0001634848
- Entity type: Corporation
- Jurisdiction: GEORGIA
- Incorporated: 2011
- Address: 1005 ALDERMAN DRIVE, ALPHARETTA, GA, 30005
- Phone: 678-812-1492
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Geoff Jason Meacham | Director | Alpharetta, GA |
| Robert Jason Thomas | Director | Alpharetta, GA |
| Stephen Charles Martin | Director | Alpharetta, GA |
| Michael Charles Shippel | Director | Alpharetta, GA |
| Michael Charles Shippel | Executive Officer | Alpharetta, GA |
| Richard Charles Coulon | Director | Alpharetta, GA |
| Richard Charles Coulon | Executive Officer | Alpharetta, GA |
Other filings by this issuer (3)
More